世界のDNAシークエンシングの研究、応用、臨床市場

Report Highlights

The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.

DNAシークエンシングの世界市場は、2024 年の 148 億ドルから成長し、2024 年から 2029 年の予測期間中に 18.6% の年間平均成長率 (CAGR) で、2029 年末までに 348 億ドルに達すると予測されています。

Summary:

In 2023, the global market for DNA sequencing was valued at $12.5 billion. The market is forecast to grow at a CAGR of 18.6% to reach $34.8 billion by the end of 2029.

Technological advances in sequencing techniques and rising applications of DNA sequencing in clinical diagnostics drive the market’s growth. The high cost of DNA sequencing, data interpretation and management difficulties challenge the market’s growth.

Instruments and consumables held the largest share of the market segmented by product and service in 2023, and this segment is expected to grow at a CAGR of 18.8% during the forecast period. The instruments and consumables segment is further categorized into sequencing instruments, sequencing kits and reagents, and others based on workflow. Services are also further categorized into sequencing services and software and informatics solutions.

In terms of technology, the NGS segment is forecast to grow at a CAGR of 18.9% during the forecast period. This segment accounted for 73.6% of the market in 2023 and is expected to reach a value of $25.9 billion by the end of 2029.

The biopharma segment accounted for 44.8% of the market by application in 2023. This segment is expected to grow at a CAGR of 19.0% during the forecast period, reaching a value of $15.9 billion by the end of 2029.

North America held the largest share of the market by region, with 46.9%, in 2023. Increasing R&D activities and the growing number of regional service providers are responsible for the region’s high share.

Report Scope

The report highlights the current and future market potential of DNA sequencing and provides a detailed analysis of market drivers, restraints and opportunities. The report also gives market projections for 2029 and includes a competitive environment and product analysis. The report provides market estimates and forecasts for DNA sequencing based on technology, product & service, end user, application, disease category, and region. By technology, the market is segmented into next-generation sequencing (NGS), third-generation sequencing (TGS), pyrosequencing, and Sanger sequencing. By product and service, the market is categorized into instruments and consumables or services. By end user, the market is segmented into academic and research institutes, hospitals and clinics, pharmaceutical and biotechnology companies, contract research organizations, and others. By application, the market is categorized as biopharma, microbiology, agriculture, or others. By disease category, the market is segmented into cancer, reproductive health, Mendelian disorders, and others. The report includes the company profiles of the key players, with detailed information about their business segments, financials, product portfolios, and recent developments.

By geographical region, the market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; Asia-Pacific includes China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years and for 2023 as the base year, with forecasts through 2029.

Report Synopsis

Report Includes

– 70 data tables and 59 additional tables

– An overview of the global market for DNA sequencing technologies and their applications in research, applied and clinical segments

– Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

– A market forecast for the DNA sequencing industry, and a corresponding market share analysis by products and services, end-use segment, application, disease category and region

– A look at the key market dynamics for DNA sequencing, and the regulatory scenario

– Discussion of market opportunities for DNA sequencing, industry structure, applications and business considerations of sequencing technologies, along with the ongoing changes in the structure of the MedTech industry

– Review of the leading next-generation sequencing (NGS) technologies, emerging applications, and the DNA sequencing-based diagnostics and research initiatives affecting the market

– Analysis of patents related to novel sequencing technologies, as well as clinical trials

– A discussion of ESG challenges and ESG practices in the industry

– Insights into the major acquisitions and strategic alliances, competitive benchmarking of sequencing industry participants and their growth strategies

– Market share analysis of the leading companies, as well as company profiles, including Illumina Inc., Thermo Fisher Scientific Inc., Pacific Biosciences (PacBio), and Oxford Nanopore Technologies Ltd.

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Insights

Chapter 2 Market Overview

Importance of DNA

Genetic Variation and Analysis

History of Sequencing

NGS (Second-generation Sequencing)

TGS (Long-read Sequencing)

Research and Applied Applications

R&D Applications

Applied Applications

Direct to Consumer

Biopharma

Agriculture

Forensics

Microbiome

Synthetic Biology

Chapter 3 Market Dynamics

Market Dynamics Snapshot

Market Drivers

Technological Advances in Sequencing Techniques

Rising Applications of DNA Sequencing in Clinical Diagnostics

Market Restraints

High Cost of DNA Sequencing

Data Interpretation and Management Challenges

Market Opportunities

Expansion of Precision Medicine

Growth in NIPT

Chapter 4 Emerging Technologies

Long-read Sequencing Technologies

SMRT Sequencing

Nanopore Sequencing

Spatial Genomics and Transcriptomics

Single-cell DNA Sequencing

Ultra-low Input Sequencing

CRISPR-Cas9 and Genome-editing Integration with Sequencing Technologies

AI and Machine Learning in DNA Sequencing

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown

Global DNA Sequencing Market Analysis by Product and Service

Instruments and Consumables

Services

Global DNA Sequencing Market Analysis by Technology

NGS

TGS

Sanger Sequencing

Pyrosequencing

Global DNA Sequencing Market Analysis by Application

Biopharma

Microbiology

Agriculture

Others (Synthetic Biology, Population Genomics, and Consumer Genomics)

Global DNA Sequencing Market Analysis by End User

Market Size and Forecast

Academic and Research Institutes

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Clinical Research

Others (Agricultural Institutions, Forensic Labs)

Global DNA Sequencing Market Analysis by Disease Category

Market Size and Forecast

Cancer

Reproductive Health

Mendelian Disorders

Others (Cardiology, Metabolic/Immune, Neurology, Transplant, Clinical)

Geographic Breakdown

Global DNA Sequencing Market Analysis by Region

Market Size and Forecast

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 6 Competitive Landscape

Overview

Partnerships

Investments and Funding

Patent Analysis

Chapter 7 ESG Perspective

Introduction

ESG Performance in the Market

ESG Practices in the DNA Sequencing Industry

Environmental Performance

Social Performance

Governance Performance

ESG Risk Ratings in the DNA Sequencing Industry

Concluding Remarks from BCC Research

Chapter 8 Appendix

Methodology

Sources

Abbreviations

Company Profiles

AGILENT TECHNOLOGIES INC.

BGI

1. HOFFMANN-LA ROCHE LTD.

GUARDANT HEALTH

ILLUMINA INC.

MYRIAD GENETICS INC.

OXFORD NANOPORE TECHNOLOGIES PLC.

PACBIO

QIAGEN

THERMO FISHER SCIENTIFIC INC.

Other Key Companies Offering DNA Sequencing Services

10X GENOMICS

CROWN BIOSCIENCE

EUROFINS GENOMICS

GENEWIZ, FROM AZENTA LIFE SCIENCES

INTEGRATED DNA TECHNOLOGIES, INC

MACROGEN

NOVOGENE CO., LTD.

REVVITY

List of Tables

Summary Table : Global DNA Sequencing Market, by Region, Through 2029

Table 1 : DNA Chemical Building Blocks

Table 2 : DNA Transcription and Translation

Table 3 : Long-range DNA Structure

Table 4 : Types of Genetic Variation

Table 5 : Molecular Diagnostic Technology Platforms

Table 6 : Genome Coverage of PCR, Microarray, and NGS Technology Platforms

Table 7 : DNA Sequencing Historical Timeline, 1970s to Present

Table 8 : Main Sequencing Applications

Table 9 : Genetic Analysis Platform Comparison

Table 10 : Sequencing Impact on Agricultural Product Classes

Table 11 : Key Applications in Forensics/Human Identity Sequencing

Table 12 : Key Applications in Microbial Sequencing

Table 13 : Global DNA Sequencing Market, by Product and Service, Through 2029

Table 14 : DNA Sequencing Instruments and Consumables Offered by Major Companies

Table 15 : Global DNA Sequencing Market for Instruments and Consumables, by Region, Through 2029

Table 16 : Global DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029

Table 17 : Classification of Sequencing Instruments Based on Capacity, Sequencing Capabilities, Read Length, and Application

Table 18 : Global DNA Sequencing Market for Instruments, by Region, Through 2029

Table 19 : Global DNA Sequencing Market for Kits and Reagents, by Region, Through 2029

Table 20 : Global DNA Sequencing Market for Services, by Region, Through 2029

Table 21 : Global DNA Sequencing Market for Services, by Workflow Component, Through 2029

Table 22 : Global DNA Sequencing Market for Services, by Region, Through 2029

Table 23 : Global DNA Sequencing Market for Software and Informatics Solutions, by Region, Through 2029

Table 24 : Global DNA Sequencing Market, by Technology, Through 2029

Table 25 : Global NGS Market, by Region, Through 2029

Table 26 : Different Generations of NGS platforms

Table 27 : Global TGS Market, by Region, Through 2029

Table 28 : Global Sanger Sequencing Market, by Region, Through 2029

Table 29 : Global Pyrosequencing Market, by Region, Through 2029

Table 30 : Global DNA Sequencing Market, by Application, Through 2029

Table 31 : Global DNA Sequencing Market in Biopharma, by Region, Through 2029

Table 32 : Global DNA Sequencing Market in Microbiology, by Region, Through 2029

Table 33 : Global DNA Sequencing Market in Agriculture, by Region, Through 2029

Table 34 : Global DNA Sequencing Market in Other Applications (Synthetic Biology, Population Genomics, and Consumer Genomics), by Region, Through 2029

Table 35 : Global DNA Sequencing Market, by End User, Through 2029

Table 36 : Global DNA Sequencing Market for Academic and Research Institutes, by Region, Through 2029

Table 37 : Global DNA Sequencing Market for Hospitals and Clinics, by Region, Through 2029

Table 38 : Global DNA Sequencing Market for Pharmaceutical and Biotechnology Companies, by Region, Through 2029

Table 39 : Global DNA Sequencing Market for Clinical Research, by Region, Through 2029

Table 40 : Key Applications in Forensics/Human Identity Sequencing

Table 41 : Global DNA Sequencing Market for Other End Users, by Region, Through 2029

Table 42 : Global DNA Sequencing Market, by Disease Category, Through 2029

Table 43 : Global DNA Sequencing Market for Cancer, by Region, Through 2029

Table 44 : Global DNA Sequencing Market for Reproductive Health, by Region, Through 2029

Table 45 : Global DNA Sequencing Market for Mendelian Disorders, by Region, Through 2029

Table 46 : Global DNA Sequencing Market for Other Diseases, by Region, Through 2029

Table 47 : Global DNA Sequencing Market, by Region, Through 2029

Table 48 : North American DNA Sequencing Market, by Country, Through 2029

Table 49 : North American DNA Sequencing Market, by Product and Service, Through 2029

Table 50 : North American DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029

Table 51 : North American DNA Sequencing Market for Services, by Workflow Component, Through 2029

Table 52 : North American DNA Sequencing Market, by Technology, Through 2029

Table 53 : North American DNA Sequencing Market, by Application, Through 2029

Table 54 : North American DNA Sequencing Market, by End User, Through 2029

Table 55 : North American DNA Sequencing Market, Category, Through 2029

Table 56 : European DNA Sequencing Market, by Country, Through 2029

Table 57 : European DNA Sequencing Market, by Product and Service, Through 2029

Table 58 : European DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029

Table 59 : European DNA Sequencing Market for Services, by Workflow Component, Through 2029

Table 60 : European DNA Sequencing Market, by Technology, Through 2029

Table 61 : European DNA Sequencing Market, by Application, Through 2029

Table 62 : European DNA Sequencing Market, by End User, Through 2029

Table 63 : European DNA Sequencing Market, by Disease Category, Through 2029

Table 64 : Asia-Pacific DNA Sequencing Market, by Country, Through 2029

Table 65 : Asia-Pacific DNA Sequencing Market, by Product and Service, Through 2029

Table 66 : Asia-Pacific DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029

Table 67 : Asia-Pacific DNA Sequencing Market for Services, by Workflow Component, Through 2029

Table 68 : Asia-Pacific DNA Sequencing Market, by Technology, Through 2029

Table 69 : Asia-Pacific DNA Sequencing Market, by Application, Through 2029

Table 70 : Asia-Pacific DNA Sequencing Market, by End User, Through 2029

Table 71 : Asia-Pacific DNA Sequencing Market, by Disease Category, Through 2029

Table 72 : RoW DNA Sequencing Market, by Product and Service, Through 2029

Table 73 : RoW DNA Sequencing Market for Instruments and Consumables, by Workflow Component, Through 2029

Table 74 : RoW DNA Sequencing Market for Services, by Workflow Component, Through 2029

Table 75 : RoW DNA Sequencing Market, by Technology, Through 2029

Table 76 : RoW DNA Sequencing Market, by Application, Through 2029

Table 77 : RoW DNA Sequencing Market, by End User, Through 2029

Table 78 : RoW DNA Sequencing Market, by Disease Category, Through 2029

Table 79 : Top DNA Sequencing Companies, 2023

Table 80 : Select Strategic Alliances in the DNA Sequencing Industry, 2022–2024

Table 81 : Major Funding Activities in the DNA Sequencing Industry, 2023 and 2024

Table 82 : Active Patents of Key Competitor Companies, 2024

Table 83 : Key Focus Areas in ESG Metrics

Table 84 : Environmental Performance Initiatives in the DNA Sequencing Market

Table 85 : Social Performance Initiatives in DNA Sequencing Market

Table 86 : Governance Performance Initiatives in DNA Sequencing Market

Table 87 : ESG Rankings for Key Players in DNA Sequencing Market, 2024*

Table 88 : Information Sources in This Report

Table 89 : Abbreviations Used in the DNA Sequencing Market

Table 90 : Agilent Technologies Inc.: Company Snapshot

Table 91 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023

Table 92 : Agilent Technologies Inc.: Product Portfolio

Table 93 : Agilent Technologies Inc.: News/Key Developments, 2023

Table 94 : BGI: Company Snapshot

Table 95 : BGI: Financial Performance, FY 2022 and 2023

Table 96 : BGI: Product Portfolio

Table 97 : F. Hoffmann-La Roche Ltd.: Company Snapshot

Table 98 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023

Table 99 : F. Hoffmann-La Roche Ltd.: Product Portfolio

Table 100 : F. Hoffmann-La Roche Ltd.: News/Key Developments, 2022–2024

Table 101 : Guardant Health: Company Snapshot

Table 102 : Guardant Health: Financial Performance, FY 2022 and 2023

Table 103 : Guardant Health: Product Portfolio

Table 104 : Guardant Health: News/Key Developments, 2022-2024

Table 105 : Illumina Inc.: Company Snapshot

Table 106 : Illumina Inc.: Financial Performance, FY 2022 and 2023

Table 107 : Illumina Inc.: Product Portfolio

Table 108 : Illumina Inc.: News/Key Developments, 2023 and 2024

Table 109 : Myriad Genetics Inc.: Company Snapshot

Table 110 : Myriad Genetics Inc.: Financial Performance, FY 2022 and 2023

Table 111 : Myriad Genetics Inc.: Product Portfolio

Table 112 : Myriad Genetics Inc.: News/Key Developments, 2023

Table 113 : Oxford Nanopore Technologies plc.: Company Snapshot

Table 114 : Oxford Nanopore Technologies plc.: Financial Performance, FY 2022 and 2023

Table 115 : Oxford Nanopore Technologies plc.: Product Portfolio

Table 116 : Oxford Nanopore Technologies plc.: News/Key Developments, 2024

Table 117 : PacBio: Company Snapshot

Table 118 : PacBio: Financial Performance, FY 2022 and 2023

Table 119 : PacBio: Product Portfolio

Table 120 : PacBio: News/Key Developments, 2023 and 2024

Table 121 : Qiagen: Company Snapshot

Table 122 : Qiagen: Financial Performance, FY 2022 and 2023

Table 123 : Qiagen: Product Portfolio

Table 124 : Qiagen: News/Key Developments, 2023 and 2024

Table 125 : Thermo Fisher Scientific Inc.: Company Snapshot

Table 126 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023

Table 127 : Thermo Fisher Scientific Inc.: Product Portfolio

Table 128 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure : Global DNA Sequencing Market Shares, by Region, 2023

Figure 1 : Evolution of Sequencing Technologies, 1975-2015

Figure 2 : Snapshot of Market Dynamics for DNA Sequencing

Figure 3 : Global DNA Sequencing Market Shares, by Product and Service, 2023

Figure 4 : Global DNA Sequencing Market for Instruments and Consumables, by Region, 2021–2029

Figure 5 : Global DNA Sequencing Market for Services, by Region, 2021–2029

Figure 6 : Global DNA Sequencing Market Shares, by Technology, 2023

Figure 7 : Different NGS Technologies and Their Applications

Figure 8 : Global NGS Market, 2021–2029

Figure 9 : Global NGS Market, by Region, 2021–2029

Figure 10 : Global TGS Market, 2021–2029

Figure 11 : Global TGS Market, by Region, 2021–2029

Figure 12 : Global Sanger Sequencing Market, 2021–2029

Figure 13 : Global Sanger Sequencing Market, by Region, 2021–2029

Figure 14 : Global Pyrosequencing Market, 2021–2029

Figure 15 : Global Pyrosequencing Market, by Region, 2021–2029

Figure 16 : Global DNA Sequencing Market Shares, by Application, 2023

Figure 17 : Global DNA Sequencing Market in Biopharma, 2021–2029

Figure 18 : Global DNA Sequencing Market in Microbiology, 2021–2029

Figure 19 : Global DNA Sequencing Market in Agriculture, 2021–2029

Figure 20 : Global DNA Sequencing Market in Other Applications (Synthetic Biology, Population Genomics, and Consumer Genomics), 2021–2029

Figure 21 : Global DNA Sequencing Market Shares, by End User, 2023

Figure 22 : Global DNA Sequencing Market for Academic and Research Institutes, 2021–2029

Figure 23 : Global DNA Sequencing Market for Hospitals and Clinics, 2021–2029

Figure 24 : Global DNA Sequencing Market for Pharmaceutical and Biotechnology Companies, 2021–2029

Figure 25 : Global DNA Sequencing Market for Clinical Research, 2021–2029

Figure 26 : Global DNA Sequencing Market for Other End Users, 2021–2029

Figure 27 : Global DNA Sequencing Market Shares, by Disease Category, 2023

Figure 28 : Global DNA Sequencing Market for Cancer, 2021–2029

Figure 29 : Global DNA Sequencing Market for Reproductive Health, 2021–2029

Figure 30 : Global DNA Sequencing Market for Mendelian Disorders, 2021–2029

Figure 31 : Global DNA Sequencing Market for Other Diseases, 2021–2029

Figure 32 : Global DNA Sequencing Market Shares, by Region, 2023

Figure 33 : Global DNA Sequencing Market, by Region, 2021–2029

Figure 34 : North American DNA Sequencing Market Shares, by Country, 2023

Figure 35 : The U.S. DNA Sequencing Market, 2021−2029

Figure 36 : Canadian DNA Sequencing Market, 2021−2029

Figure 37 : Mexican DNA Sequencing Market, 2021−2029

Figure 38 : European DNA Sequencing Market Shares, by Country, 2023

Figure 39 : German DNA Sequencing Market, 2021−2029

Figure 40 : The U.K. DNA Sequencing Market, 2021−2029

Figure 41 : French DNA Sequencing Market, 2021−2029

Figure 42 : Italian DNA Sequencing Market, 2021−2029

Figure 43 : Spanish DNA Sequencing Market, 2021−2029

Figure 44 : Rest of European DNA Sequencing Market, 2021−2029

Figure 45 : Asia-Pacific DNA Sequencing Market Shares, by Country, 2023

Figure 46 : Chinese DNA Sequencing Market, 2021−2029

Figure 47 : Japanese DNA Sequencing Market, 2021−2029

Figure 48 : Indian DNA Sequencing Market, 2021−2029

Figure 49 : Australian DNA Sequencing Market, 2021−2029

Figure 50 : South Korean DNA Sequencing Market, 2021−2029

Figure 51 : Rest of Asia-Pacific DNA Sequencing Market, 2021−2029

Figure 52 : Snapshot of ESG Pillars

Figure 53 : Advantages of ESG for Companies

Figure 54 : Share of Biotech Companies Providing ESG Disclosure, 2022

Figure 55 : Share of Biotech Companies Providing ESG Disclosure, by Disclosure Type, 2022

Figure 56 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023

Figure 57 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023

Figure 58 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023

Figure 59 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023

Figure 60 : Guardant Health: Revenue Share, by Business Unit, FY 2023

Figure 61 : Guardant Health: Revenue Share, by Country/Region, FY 2023

Figure 62 : Illumina Inc.: Revenue Share, by Business Unit, FY 2023

Figure 63 : Illumina Inc.: Revenue Share, by Country/Region, FY 2023

Figure 64 : Myriad Genetics Inc.: Revenue Share, by Business Unit, FY 2023

Figure 65 : Myriad Genetics Inc.: Revenue Share, by Country/Region, FY 2023

Figure 66 : Oxford Nanopore Technologies plc.: Revenue Share, by Business Unit, FY 2023

Figure 67 : Oxford Nanopore Technologies plc.: Revenue Share, by Country/Region, FY 2023

Figure 68 : PacBio: Revenue Share, by Business Unit, FY 2023

Figure 69 : PacBio: Revenue Share, by Country/Region, FY 2023

Figure 70 : Qiagen: Revenue Share, by Business Unit, FY 2023

Figure 71 : Qiagen: Revenue Share, by Country/Region, FY 2023

Figure 72 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2023

Figure 73 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 食品小売業およびEコマースにおけるAIの世界市場 2025-11-14
• 免疫療法薬の世界市場 2025-11-12
• 農業におけるAIの世界市場 2025-11-10
• 固体酸化物形燃料電池の技術と世界市場 2025-11-07
• 世界の電気アーク炉市場 2025-11-07

BCC Research  出版レポート一覧